泰它西普治疗IGA肾病的优异疗效和安全性早已显露在销售收入里

新浪财经
Nov 09, 2025

来源:大隐无言北京时间2025年11月9日,在美国休斯顿举行的2025年美国肾脏病学会(ASN)年会上,荣昌生物在“高影响力临床试验(high impact clinical trial)”专题会议上重磅发布了泰它西普治疗IgA肾病的中国Ⅲ期临床研究A阶段数据。数据显示泰它西普治疗IGA肾病不仅可以显著降低蛋白尿、同时维持肾功能稳定,展示出优异疗效和安全性。数据显示泰它西普组患者在治疗第39周时...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10